ID   GALT_HUMAN              Reviewed;         379 AA.
AC   P07902; B4E097; E7ET32; Q14355; Q14356; Q14357; Q14358; Q14359;
AC   Q14360; Q14361; Q14363; Q14364; Q14365; Q14369; Q14370; Q14371;
AC   Q14372; Q14373; Q14374; Q14375; Q14377; Q14378; Q14380; Q14381;
AC   Q14382; Q14383; Q14384; Q14385; Q14386; Q14387; Q14389; Q16766;
AC   Q53XK1; Q5VZ81; Q96BY1;
DT   01-AUG-1988, integrated into UniProtKB/Swiss-Prot.
DT   15-JUL-1998, sequence version 3.
DT   15-MAR-2017, entry version 199.
DE   RecName: Full=Galactose-1-phosphate uridylyltransferase;
DE            Short=Gal-1-P uridylyltransferase;
DE            EC=2.7.7.12;
DE   AltName: Full=UDP-glucose--hexose-1-phosphate uridylyltransferase;
GN   Name=GALT;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Fibroblast;
RX   PubMed=2840550;
RA   Reichardt J.K.V., Berg P.;
RT   "Cloning and characterization of a cDNA encoding human galactose-1-
RT   phosphate uridyl transferase.";
RL   Mol. Biol. Med. 5:107-122(1988).
RN   [2]
RP   SEQUENCE REVISION.
RX   PubMed=2233247;
RA   Flach J.E., Reichardt J.K.V., Elsas L.J. II;
RT   "Sequence of a cDNA encoding human galactose-1-phosphate uridyl
RT   transferase.";
RL   Mol. Biol. Med. 7:365-369(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANT GALCT ARG-188, AND
RP   INVOLVEMENT IN GALCT.
RX   PubMed=1427861; DOI=10.1016/S0888-7543(05)80244-7;
RA   Leslie N.D., Immerman E.B., Flach J.E., Florez M.,
RA   Fridovich-Keil J.L., Elsas L.J.;
RT   "The human galactose-1-phosphate uridyltransferase gene.";
RL   Genomics 14:474-480(1992).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   ASP-314.
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E.,
RA   Howe K.L., Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Ashwell R.I.S.,
RA   Babbage A.K., Babbage S., Bagguley C.L., Bailey J., Banerjee R.,
RA   Barker D.J., Barlow K.F., Bates K., Beasley H., Beasley O., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burford D., Burrill W.,
RA   Burton J., Carder C., Carter N.P., Chapman J.C., Chen Y., Clarke G.,
RA   Clark S.Y., Clee C.M., Clegg S., Collier R.E., Corby N., Crosier M.,
RA   Cummings A.T., Davies J., Dhami P., Dunn M., Dutta I., Dyer L.W.,
RA   Earthrowl M.E., Faulkner L., Fleming C.J., Frankish A.,
RA   Frankland J.A., French L., Fricker D.G., Garner P., Garnett J.,
RA   Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M.,
RA   Lovell J., Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S.,
RA   McLay K.E., McMurray A., Milne S., Nickerson T., Nisbett J.,
RA   Nordsiek G., Pearce A.V., Peck A.I., Porter K.M., Pandian R.,
RA   Pelan S., Phillimore B., Povey S., Ramsey Y., Rand V., Scharfe M.,
RA   Sehra H.K., Shownkeen R., Sims S.K., Skuce C.D., Smith M.,
RA   Steward C.A., Swarbreck D., Sycamore N., Tester J., Thorpe A.,
RA   Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Williams S.A., Wilming L., Wray P.W.,
RA   Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S.,
RA   Rogers J., Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   ASP-314.
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   REVIEW ON GALCT MUTATIONS.
RX   PubMed=1301925; DOI=10.1002/humu.1380010303;
RA   Reichardt J.K.V.;
RT   "Genetic basis of galactosemia.";
RL   Hum. Mutat. 1:190-196(1992).
RN   [10]
RP   REVIEW ON GALCT MUTATIONS.
RX   PubMed=10408771;
RX   DOI=10.1002/(SICI)1098-1004(1999)13:6<417::AID-HUMU1>3.0.CO;2-0;
RA   Tyfield L., Reichardt J., Fridovich-Keil J., Croke D.T.,
RA   Elsas L.J. II, Strobl W., Kozak L., Coskun T., Novelli G., Okano Y.,
RA   Zekanowski C., Shin Y., Boleda M.D.;
RT   "Classical galactosemia and mutations at the galactose-1-phosphate
RT   uridyl transferase 'GALT' gene.";
RL   Hum. Mutat. 13:417-430(1999).
RN   [11]
RP   BIOPHYSICOCHEMICAL PROPERTIES, VARIANTS GALCT ASN-34; GLN-132;
RP   LEU-168; THR-170; PRO-227; GLN-259; VAL-291 AND PRO-327, AND
RP   CHARACTERIZATION OF VARIANTS GALCT ASN-34; GLN-132; LEU-135; LEU-168;
RP   THR-170; HIS-185; ARG-188; CYS-201; LYS-220; SER-223; PRO-227;
RP   GLN-259; ASN-278; PHE-289; VAL-291 AND PRO-327.
RX   PubMed=22461411; DOI=10.1002/humu.22093;
RA   Tang M., Facchiano A., Rachamadugu R., Calderon F., Mao R.,
RA   Milanesi L., Marabotti A., Lai K.;
RT   "Correlation assessment among clinical phenotypes, expression analysis
RT   and molecular modeling of 14 novel variations in the human galactose-
RT   1-phosphate uridylyltransferase gene.";
RL   Hum. Mutat. 33:1107-1115(2012).
RN   [12]
RP   VARIANTS GALCT ARG-188 AND TRP-333.
RX   PubMed=1897530;
RA   Reichardt J.K.V., Packman S., Woo S.L.C.;
RT   "Molecular characterization of two galactosemia mutations: correlation
RT   of mutations with highly conserved domains in galactose-1-phosphate
RT   uridyl transferase.";
RL   Am. J. Hum. Genet. 49:860-867(1991).
RN   [13]
RP   VARIANTS GALCT MET-44 AND LYS-142, AND VARIANTS MET-62 AND ASP-314.
RX   PubMed=2011574; DOI=10.1073/pnas.88.7.2633;
RA   Reichardt J.K.V., Woo S.L.C.;
RT   "Molecular basis of galactosemia: mutations and polymorphisms in the
RT   gene encoding human galactose-1-phosphate uridylyltransferase.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:2633-2637(1991).
RN   [14]
RP   ERRATUM.
RA   Reichardt J.K.V., Woo S.L.C.;
RL   Proc. Natl. Acad. Sci. U.S.A. 88:7457-7457(1991).
RN   [15]
RP   VARIANTS GALCT PRO-74 AND SER-171, AND VARIANT LEU-135.
RX   PubMed=1610789; DOI=10.1021/bi00139a002;
RA   Reichardt J.K.V., Levy H.L., Woo S.L.C.;
RT   "Molecular characterization of two galactosemia mutations and one
RT   polymorphism: implications for structure-function analysis of human
RT   galactose-1-phosphate uridyltransferase.";
RL   Biochemistry 31:5430-5433(1992).
RN   [16]
RP   VARIANTS GALCT TRP-148 AND PRO-195.
RX   PubMed=1373122; DOI=10.1016/0888-7543(92)90453-Y;
RA   Reichardt J.K.V., Belmont J.W., Levy H.L., Woo S.L.C.;
RT   "Characterization of two missense mutations in human galactose-1-
RT   phosphate uridyltransferase: different molecular mechanisms for
RT   galactosemia.";
RL   Genomics 12:596-600(1992).
RN   [17]
RP   VARIANT GALCT GLN-319.
RX   PubMed=8499924; DOI=10.1093/hmg/2.3.325;
RA   Reichardt J.K.V., Novelli G., Dallapiccola B.;
RT   "Molecular characterization of the H319Q galactosemia mutation.";
RL   Hum. Mol. Genet. 2:325-326(1993).
RN   [18]
RP   VARIANT GALCT ASP-314.
RX   PubMed=8112740; DOI=10.1007/BF00210604;
RA   Lin H.-C., Kirby L.T., Ng W.G., Reichardt J.K.V.;
RT   "On the molecular nature of the Duarte variant of galactose-1-
RT   phosphate uridyl transferase (GALT).";
RL   Hum. Genet. 93:167-169(1994).
RN   [19]
RP   VARIANTS GALCT.
RX   PubMed=7887416;
RA   Elsas L.J., Langley S.D., Steele E., Evinger J., Frodovich-Keil J.L.,
RA   Brown A., Singh R., Fernhoff P., Hjelm L.N., Dembure P.P.;
RT   "Galactosemia: a strategy to identify new biochemical phenotypes and
RT   molecular genotypes.";
RL   Am. J. Hum. Genet. 56:630-639(1995).
RN   [20]
RP   VARIANTS GALCT LEU-135; ALA-151 AND ARG-188.
RX   PubMed=7887417;
RA   Fridovich-Keil J.L., Langley S.D., Mazur L.A., Lennon J.C.,
RA   Dembure P.P., Elsas L.J. II;
RT   "Identification and functional analysis of three distinct mutations in
RT   the human galactose-1-phosphate uridyltransferase gene associated with
RT   galactosemia in a single family.";
RL   Am. J. Hum. Genet. 56:640-646(1995).
RN   [21]
RP   VARIANTS GALCT CYS-67 AND VAL-330.
RX   PubMed=8598637; DOI=10.1007/BF02436001;
RA   Sommer M., Gathof B.S., Podskarbi T., Giugliani R., Kleinlein B.,
RA   Shin Y.S.;
RT   "Mutations in the galactose-1-phosphate uridyltransferase gene of two
RT   families with mild galactosaemia variants.";
RL   J. Inherit. Metab. Dis. 18:567-576(1995).
RN   [22]
RP   VARIANTS GALCT HIS-231 AND TRP-333, AND VARIANT ASP-314.
RX   PubMed=7550229; DOI=10.1002/humu.1380060108;
RA   Ashino J., Okano Y., Suyama I., Yamazaki T., Yoshino M., Furuyama J.,
RA   Lin H.-C., Reichardt J.K.V., Isshiki G.;
RT   "Molecular characterization of galactosemia (type 1) mutations in
RT   Japanese.";
RL   Hum. Mutat. 6:36-43(1995).
RN   [23]
RP   VARIANTS GALCT CYS-55 AND PHE-329.
RX   PubMed=8741038; DOI=10.1007/BF01955270;
RA   Shin Y.S., Gathof B.S., Podskarbi T., Sommer M., Giugliani R.,
RA   Gresser U.;
RT   "Three missense mutations in the galactose-1-phosphate
RT   uridyltransferase gene of three families with mild galactosaemia.";
RL   Eur. J. Pediatr. 155:393-397(1996).
RN   [24]
RP   VARIANTS GALCT LEU-150; THR-183; ARG-188 AND GLN-319.
RX   PubMed=8956044;
RX   DOI=10.1002/(SICI)1098-1004(1996)8:4<369::AID-HUMU12>3.3.CO;2-L;
RA   Maceratesi P., Sangiuolo F., Novelli G., Ninfali P., Magnani M.,
RA   Reichardt J.K.V., Dallapiccola B.;
RT   "Three new mutations (P183T, V150L, 528insG) and eleven sequence
RT   polymorphisms in Italian patients with galactose-1-phosphate
RT   uridyltransferase (GALT) deficiency.";
RL   Hum. Mutat. 8:369-372(1996).
RN   [25]
RP   VARIANT GALCT THR-183.
RX   PubMed=8869397; DOI=10.1007/BF00878541;
RA   Ninfali P., Bresolin N., Dallapiccola B., Novelli G.;
RT   "Molecular basis of galactose-1-phosphate uridyltransferase deficiency
RT   involving skeletal muscle.";
RL   J. Neurol. 243:102-103(1996).
RN   [26]
RP   VARIANTS GALCT TYR-28; ASN-32; PRO-38; GLY-123; LEU-143 AND LEU-325.
RX   PubMed=9222760;
RX   DOI=10.1002/(SICI)1098-1004(1997)10:1<49::AID-HUMU7>3.3.CO;2-H;
RA   Greber-Platzer S., Guldberg P., Scheibenreiter S., Item C.,
RA   Schuller E., Patel N., Strobl W.;
RT   "Molecular heterogeneity of classical and Duarte galactosemia:
RT   mutation analysis by denaturing gradient gel electrophoresis.";
RL   Hum. Mutat. 10:49-57(1997).
RN   [27]
RP   VARIANTS GALCT LYS-142; ASN-285; TYR-294 AND THR-320.
RX   PubMed=10220154;
RX   DOI=10.1002/(SICI)1098-1004(1999)13:4<339::AID-HUMU17>3.0.CO;2-V;
RA   Seyrantepe V., Ozguc M., Coskun T., Ozalp I., Reichardt J.K.V.;
RT   "Identification of mutations in the galactose-1-phosphate
RT   uridyltransferase (GALT) gene in 16 Turkish patients with
RT   galactosemia, including a novel mutation of F294Y.";
RL   Hum. Mutat. 13:339-339(1999).
RN   [28]
RP   VARIANTS GALCT ALA-23; LEU-135; MET-138; GLN-184; ARG-188; PRO-195;
RP   SER-251; ASN-285; LYS-344 AND ASP-345, AND VARIANT ASP-314.
RX   PubMed=11754113; DOI=10.1002/humu.9005;
RA   Yang Y.P., Corley N., Garcia-Heras J.;
RT   "Molecular analysis in newborns from Texas affected with
RT   galactosemia.";
RL   Hum. Mutat. 19:82-83(2002).
RN   [29]
RP   VARIANTS GALCT HIS-9; THR-129 AND ILE-342.
RX   PubMed=11919338; DOI=10.1203/00006450-200204000-00018;
RA   Item C., Hagerty B.P., Muhl A., Greber-Platzer S.,
RA   Stockler-Ipsiroglu S., Strobl W.;
RT   "Mutations at the galactose-1-p-uridyltransferase gene in infants with
RT   a positive galactosemia newborn screening test.";
RL   Pediatr. Res. 51:511-516(2002).
RN   [30]
RP   VARIANTS GALCT GLN-51; TRP-135; ASN-229 AND HIS-252.
RX   PubMed=15841485; DOI=10.1002/humu.9330;
RA   Bosch A.M., Ijlst L., Oostheim W., Mulders J., Bakker H.D.,
RA   Wijburg F.A., Wanders R.J., Waterham H.R.;
RT   "Identification of novel mutations in classical galactosemia.";
RL   Hum. Mutat. 25:502-502(2005).
RN   [31]
RP   VARIANTS GALCT HIS-28; HIS-33; ALA-181; SER-185; GLY-192 AND ALA-265.
RX   PubMed=17041746; DOI=10.1007/s10545-006-0356-2;
RA   Gort L., Boleda M.D., Tyfield L., Vilarinho L., Rivera I.,
RA   Cardoso M.L., Santos-Leite M., Giros M., Briones P.;
RT   "Mutational spectrum of classical galactosaemia in Spain and
RT   Portugal.";
RL   J. Inherit. Metab. Dis. 29:739-742(2006).
RN   [32]
RP   VARIANTS GALCT HIS-185; CYS-201; LYS-220; SER-223; ASN-278 AND
RP   PHE-289.
RX   PubMed=17876724; DOI=10.1007/s10545-007-0461-x;
RA   Calderon F.R., Nelson L., Dobrowolski P., Sinitsyna I., Phansalkar A.,
RA   Longo N., Pasquali M., Mao R.;
RT   "Combination of enzyme analysis, allele-specific PCR and sequencing to
RT   detect mutations in the GALT gene.";
RL   J. Inherit. Metab. Dis. 30:818-818(2007).
RN   [33]
RP   VARIANTS GALCT ARG-112 AND ARG-188, AND VARIANT ASP-314.
RX   PubMed=18956253; DOI=10.1007/s10545-008-0905-y;
RA   Velazquez-Aragon J., Alcantara-Ortigoza M.A., Vela-Amieva M.,
RA   Monroy S., Martinez-Cruz V., Todd-Quinones C., Gonzalez-del Angel A.;
RT   "Low allelic heterogeneity in a sample of Mexican patients with
RT   classical galactosaemia.";
RL   J. Inherit. Metab. Dis. 31:S333-S337(2008).
RN   [34]
RP   VARIANTS GALCT HIS-89; ARG-103; ALA-166; SER-171; PHE-181; LEU-185;
RP   ARG-188; ARG-285; GLN-319 AND LEU-333, AND VARIANT ASP-314.
RX   PubMed=23022339; DOI=10.1016/j.cca.2012.09.017;
RA   Singh R., Thapa B.R., Kaur G., Prasad R.;
RT   "Biochemical and molecular characterization of GALT gene from Indian
RT   galactosemia patients: Identification of 10 novel mutations and their
RT   structural and functional implications.";
RL   Clin. Chim. Acta 414:191-196(2012).
RN   [35]
RP   VARIANTS GALCT LEU-135; GLN-148; ASP-175; SER-185; ARG-188; CYS-231;
RP   HIS-231; ASN-285 AND ASP-314, AND CHARACTERIZATION OF VARIANTS GALCT
RP   LEU-135; ASP-175 AND ARG-188.
RX   PubMed=25614870; DOI=10.1002/mgg3.94;
RA   Coelho A.I., Trabuco M., Ramos R., Silva M.J., Tavares de Almeida I.,
RA   Leandro P., Rivera I., Vicente J.B.;
RT   "Functional and structural impact of the most prevalent missense
RT   mutations in classic galactosemia.";
RL   Mol. Genet. Genomic Med. 2:484-496(2014).
RN   [36]
RP   VARIANTS GALCT PRO-33; ASN-34; VAL-83; THR-142; ARG-188; SER-244;
RP   ARG-267; VAL-267; ASP-271; ASN-285; ASP-314 AND TRP-333.
RX   PubMed=25592817; DOI=10.1016/j.gene.2015.01.013;
RA   Viggiano E., Marabotti A., Burlina A.P., Cazzorla C., D'Apice M.R.,
RA   Giordano L., Fasan I., Novelli G., Facchiano A., Burlina A.B.;
RT   "Clinical and molecular spectra in galactosemic patients from neonatal
RT   screening in northeastern Italy: Structural and functional
RT   characterization of new variations in the galactose-1-phosphate
RT   uridyltransferase (GALT) gene.";
RL   Gene 559:112-118(2015).
CC   -!- CATALYTIC ACTIVITY: UDP-alpha-D-glucose + alpha-D-galactose 1-
CC       phosphate = alpha-D-glucose 1-phosphate + UDP-alpha-D-galactose.
CC   -!- COFACTOR:
CC       Name=Fe cation; Xref=ChEBI:CHEBI:24875; Evidence={ECO:0000305};
CC       Note=Binds 1 Fe cation per subunit. {ECO:0000305};
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000305};
CC       Note=Binds 1 zinc ion per subunit. {ECO:0000305};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=1.25 mM for alpha-D-galactose 1-phosphate (at pH 8.7)
CC         {ECO:0000269|PubMed:22461411};
CC         KM=0.43 mM for UDP-glucose (at pH 8.7)
CC         {ECO:0000269|PubMed:22461411};
CC         Vmax=48 umol/min/mg enzyme {ECO:0000269|PubMed:22461411};
CC   -!- PATHWAY: Carbohydrate metabolism; galactose metabolism.
CC   -!- SUBUNIT: Homodimer. {ECO:0000305}.
CC   -!- INTERACTION:
CC       Q07912:TNK2; NbExp=3; IntAct=EBI-750827, EBI-603457;
CC       Q07912-2:TNK2; NbExp=3; IntAct=EBI-750827, EBI-11994780;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P07902-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P07902-2; Sequence=VSP_045604, VSP_045605;
CC         Note=No experimental confirmation available.;
CC   -!- DISEASE: Galactosemia (GALCT) [MIM:230400]: Inherited disorder of
CC       galactose metabolism that causes jaundice, cataracts, and mental
CC       retardation. {ECO:0000269|PubMed:10220154,
CC       ECO:0000269|PubMed:11754113, ECO:0000269|PubMed:11919338,
CC       ECO:0000269|PubMed:1373122, ECO:0000269|PubMed:1427861,
CC       ECO:0000269|PubMed:15841485, ECO:0000269|PubMed:1610789,
CC       ECO:0000269|PubMed:17041746, ECO:0000269|PubMed:17876724,
CC       ECO:0000269|PubMed:18956253, ECO:0000269|PubMed:1897530,
CC       ECO:0000269|PubMed:2011574, ECO:0000269|PubMed:22461411,
CC       ECO:0000269|PubMed:23022339, ECO:0000269|PubMed:25592817,
CC       ECO:0000269|PubMed:25614870, ECO:0000269|PubMed:7550229,
CC       ECO:0000269|PubMed:7887416, ECO:0000269|PubMed:7887417,
CC       ECO:0000269|PubMed:8112740, ECO:0000269|PubMed:8499924,
CC       ECO:0000269|PubMed:8598637, ECO:0000269|PubMed:8741038,
CC       ECO:0000269|PubMed:8869397, ECO:0000269|PubMed:8956044,
CC       ECO:0000269|PubMed:9222760}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the galactose-1-phosphate
CC       uridylyltransferase type 1 family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Galactose-1-Phosphate Uridyl Transferase
CC       (GALT); Note=Galactosemia mutation database;
CC       URL="http://bioinformatica.isa.cnr.it/GALT/GALT2.0";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M60091; AAC83409.1; -; mRNA.
DR   EMBL; M96264; AAA74450.1; -; Genomic_DNA.
DR   EMBL; L46359; AAB59606.1; -; Genomic_DNA.
DR   EMBL; L46360; AAB59604.1; -; Genomic_DNA.
DR   EMBL; L46361; AAB59605.1; -; Genomic_DNA.
DR   EMBL; L46362; AAB59603.1; -; Genomic_DNA.
DR   EMBL; L46363; AAB59607.1; -; Genomic_DNA.
DR   EMBL; L46364; AAB59584.1; -; Genomic_DNA.
DR   EMBL; L46365; AAB59585.1; -; Genomic_DNA.
DR   EMBL; L46691; AAB59586.1; -; Genomic_DNA.
DR   EMBL; L46692; AAB59588.1; -; Genomic_DNA.
DR   EMBL; L46693; AAB59587.1; -; Genomic_DNA.
DR   EMBL; L46694; AAB59589.1; -; Genomic_DNA.
DR   EMBL; L46698; AAB59590.1; -; Genomic_DNA.
DR   EMBL; L46699; AAB59608.1; -; Genomic_DNA.
DR   EMBL; L46703; AAB59591.1; -; Genomic_DNA.
DR   EMBL; L46704; AAB59578.1; -; Genomic_DNA.
DR   EMBL; L46705; AAB59592.1; -; Genomic_DNA.
DR   EMBL; L46706; AAB59593.1; -; Genomic_DNA.
DR   EMBL; L46707; AAA81544.1; -; Genomic_DNA.
DR   EMBL; L46708; AAA81545.1; -; Genomic_DNA.
DR   EMBL; L46709; AAB59594.1; -; Genomic_DNA.
DR   EMBL; L46710; AAB59595.1; -; Genomic_DNA.
DR   EMBL; L46711; AAB59596.1; -; Genomic_DNA.
DR   EMBL; L46712; AAB59597.1; -; Genomic_DNA.
DR   EMBL; L46713; AAB59598.1; -; Genomic_DNA.
DR   EMBL; L46714; AAB59599.1; -; Genomic_DNA.
DR   EMBL; L46715; AAB59601.1; -; Genomic_DNA.
DR   EMBL; L46716; AAB59600.1; -; Genomic_DNA.
DR   EMBL; L46717; AAA81546.1; -; Genomic_DNA.
DR   EMBL; BT009852; AAP88854.1; -; mRNA.
DR   EMBL; AK303279; BAG64359.1; -; mRNA.
DR   EMBL; AL162231; CAH69856.1; -; Genomic_DNA.
DR   EMBL; AL450283; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471071; EAW58428.1; -; Genomic_DNA.
DR   EMBL; BC015045; AAH15045.1; -; mRNA.
DR   CCDS; CCDS59122.1; -. [P07902-2]
DR   CCDS; CCDS6565.1; -. [P07902-1]
DR   PIR; A44473; A44473.
DR   PIR; I57459; I57459.
DR   PIR; JL0053; JL0053.
DR   RefSeq; NP_000146.2; NM_000155.3. [P07902-1]
DR   RefSeq; NP_001245261.1; NM_001258332.1. [P07902-2]
DR   UniGene; Hs.522090; -.
DR   PDB; 1R3A; Model; -; A/B=21-379.
DR   PDB; 5IN3; X-ray; 1.73 A; A/B=1-379.
DR   PDBsum; 1R3A; -.
DR   PDBsum; 5IN3; -.
DR   ProteinModelPortal; P07902; -.
DR   SMR; P07902; -.
DR   BioGrid; 108864; 7.
DR   IntAct; P07902; 5.
DR   STRING; 9606.ENSP00000368119; -.
DR   iPTMnet; P07902; -.
DR   PhosphoSitePlus; P07902; -.
DR   BioMuta; GALT; -.
DR   DMDM; 3183522; -.
DR   EPD; P07902; -.
DR   MaxQB; P07902; -.
DR   PaxDb; P07902; -.
DR   PeptideAtlas; P07902; -.
DR   PRIDE; P07902; -.
DR   DNASU; 2592; -.
DR   Ensembl; ENST00000378842; ENSP00000368119; ENSG00000213930. [P07902-1]
DR   Ensembl; ENST00000450095; ENSP00000401956; ENSG00000213930. [P07902-2]
DR   GeneID; 2592; -.
DR   KEGG; hsa:2592; -.
DR   UCSC; uc003zve.5; human. [P07902-1]
DR   CTD; 2592; -.
DR   DisGeNET; 2592; -.
DR   GeneCards; GALT; -.
DR   GeneReviews; GALT; -.
DR   HGNC; HGNC:4135; GALT.
DR   HPA; HPA004868; -.
DR   HPA; HPA005729; -.
DR   MalaCards; GALT; -.
DR   MIM; 230400; phenotype.
DR   MIM; 606999; gene.
DR   neXtProt; NX_P07902; -.
DR   OpenTargets; ENSG00000213930; -.
DR   Orphanet; 79239; Classic galactosemia.
DR   PharmGKB; PA28548; -.
DR   eggNOG; KOG2958; Eukaryota.
DR   eggNOG; COG1085; LUCA.
DR   GeneTree; ENSGT00390000016188; -.
DR   HOGENOM; HOG000230490; -.
DR   HOVERGEN; HBG051700; -.
DR   InParanoid; P07902; -.
DR   KO; K00965; -.
DR   OMA; GQWVLVC; -.
DR   OrthoDB; EOG091G0ER8; -.
DR   PhylomeDB; P07902; -.
DR   TreeFam; TF300018; -.
DR   BRENDA; 2.7.7.12; 2681.
DR   Reactome; R-HSA-70370; Galactose catabolism.
DR   SABIO-RK; P07902; -.
DR   UniPathway; UPA00214; -.
DR   ChiTaRS; GALT; human.
DR   GeneWiki; Galactose%E2%80%941-phosphate_uridylyltransferase; -.
DR   GenomeRNAi; 2592; -.
DR   PRO; PR:P07902; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   Bgee; ENSG00000213930; -.
DR   ExpressionAtlas; P07902; baseline and differential.
DR   Genevisible; P07902; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:UniProtKB.
DR   GO; GO:0008108; F:UDP-glucose:hexose-1-phosphate uridylyltransferase activity; EXP:Reactome.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0019388; P:galactose catabolic process; TAS:Reactome.
DR   GO; GO:0006012; P:galactose metabolic process; TAS:ProtInc.
DR   GO; GO:0006258; P:UDP-glucose catabolic process; IEA:Ensembl.
DR   Gene3D; 3.30.428.10; -; 2.
DR   InterPro; IPR001937; GalP_UDPtransf1.
DR   InterPro; IPR019779; GalP_UDPtransf1_His-AS.
DR   InterPro; IPR005850; GalP_Utransf_C.
DR   InterPro; IPR005849; GalP_Utransf_N.
DR   InterPro; IPR011146; HIT-like.
DR   PANTHER; PTHR11943; PTHR11943; 1.
DR   Pfam; PF02744; GalP_UDP_tr_C; 1.
DR   Pfam; PF01087; GalP_UDP_transf; 1.
DR   PIRSF; PIRSF000808; GalT; 1.
DR   SUPFAM; SSF54197; SSF54197; 2.
DR   TIGRFAMs; TIGR00209; galT_1; 1.
DR   PROSITE; PS00117; GAL_P_UDP_TRANSF_I; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Carbohydrate metabolism; Cataract;
KW   Complete proteome; Disease mutation; Galactose metabolism; Iron;
KW   Metal-binding; Nucleotidyltransferase; Polymorphism;
KW   Reference proteome; Transferase; Zinc.
FT   CHAIN         1    379       Galactose-1-phosphate
FT                                uridylyltransferase.
FT                                /FTId=PRO_0000169882.
FT   ACT_SITE    186    186       Tele-UMP-histidine intermediate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU10033}.
FT   METAL        75     75       Zinc. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10033}.
FT   METAL       184    184       Zinc. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10033}.
FT   METAL       202    202       Iron. {ECO:0000255}.
FT   METAL       301    301       Iron. {ECO:0000255}.
FT   METAL       319    319       Iron. {ECO:0000255}.
FT   METAL       321    321       Iron. {ECO:0000255}.
FT   VAR_SEQ       1     17       MSRSGTDPQQRQQASEA -> MTLSTLCVLGPSEPTES
FT                                (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045604.
FT   VAR_SEQ      18    126       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045605.
FT   VARIANT       9      9       Q -> H (in GALCT; dbSNP:rs111033637).
FT                                {ECO:0000269|PubMed:11919338}.
FT                                /FTId=VAR_068531.
FT   VARIANT      23     23       T -> A (in GALCT; dbSNP:rs111033635).
FT                                {ECO:0000269|PubMed:11754113}.
FT                                /FTId=VAR_068532.
FT   VARIANT      28     28       D -> H (in GALCT; dbSNP:rs111033636).
FT                                {ECO:0000269|PubMed:17041746}.
FT                                /FTId=VAR_068533.
FT   VARIANT      28     28       D -> Y (in GALCT; dbSNP:rs111033636).
FT                                {ECO:0000269|PubMed:9222760}.
FT                                /FTId=VAR_002548.
FT   VARIANT      32     32       I -> N (in GALCT; mild;
FT                                dbSNP:rs111033644).
FT                                {ECO:0000269|PubMed:9222760}.
FT                                /FTId=VAR_002549.
FT   VARIANT      33     33       R -> H (in GALCT; dbSNP:rs111033829).
FT                                {ECO:0000269|PubMed:17041746}.
FT                                /FTId=VAR_068534.
FT   VARIANT      33     33       R -> P (in GALCT).
FT                                {ECO:0000269|PubMed:25592817}.
FT                                /FTId=VAR_072793.
FT   VARIANT      34     34       Y -> N (in GALCT; affects protein
FT                                stability; dbSNP:rs111033836).
FT                                {ECO:0000269|PubMed:22461411,
FT                                ECO:0000269|PubMed:25592817}.
FT                                /FTId=VAR_068535.
FT   VARIANT      38     38       Q -> P (in GALCT; dbSNP:rs111033646).
FT                                {ECO:0000269|PubMed:9222760}.
FT                                /FTId=VAR_002550.
FT   VARIANT      44     44       V -> L (in GALCT; dbSNP:rs111033647).
FT                                /FTId=VAR_002551.
FT   VARIANT      44     44       V -> M (in GALCT; reduced enzyme
FT                                activity; dbSNP:rs111033647).
FT                                {ECO:0000269|PubMed:2011574}.
FT                                /FTId=VAR_002552.
FT   VARIANT      45     45       S -> L (in GALCT; dbSNP:rs111033652).
FT                                /FTId=VAR_008042.
FT   VARIANT      51     51       R -> L (in GALCT; dbSNP:rs111033648).
FT                                /FTId=VAR_002553.
FT   VARIANT      51     51       R -> Q (in GALCT; dbSNP:rs111033648).
FT                                {ECO:0000269|PubMed:15841485}.
FT                                /FTId=VAR_023328.
FT   VARIANT      55     55       G -> C (in GALCT; dbSNP:rs111033654).
FT                                {ECO:0000269|PubMed:8741038}.
FT                                /FTId=VAR_002554.
FT   VARIANT      62     62       L -> M (in dbSNP:rs1800461).
FT                                {ECO:0000269|PubMed:2011574}.
FT                                /FTId=VAR_002555.
FT   VARIANT      67     67       R -> C (in GALCT; dbSNP:rs111033658).
FT                                {ECO:0000269|PubMed:8598637}.
FT                                /FTId=VAR_002556.
FT   VARIANT      74     74       L -> P (in GALCT; reduced enzyme
FT                                activity; dbSNP:rs111033663).
FT                                {ECO:0000269|PubMed:1610789}.
FT                                /FTId=VAR_002557.
FT   VARIANT      81     81       A -> T (in GALCT; dbSNP:rs111033665).
FT                                /FTId=VAR_002558.
FT   VARIANT      83     83       G -> V (in GALCT).
FT                                {ECO:0000269|PubMed:25592817}.
FT                                /FTId=VAR_072794.
FT   VARIANT      89     89       Y -> H (in GALCT; dbSNP:rs111033666).
FT                                {ECO:0000269|PubMed:23022339}.
FT                                /FTId=VAR_068824.
FT   VARIANT      97     97       N -> S (in GALCT; dbSNP:rs111033669).
FT                                /FTId=VAR_002559.
FT   VARIANT      98     98       D -> N (in GALCT; dbSNP:rs111033670).
FT                                /FTId=VAR_002560.
FT   VARIANT     103    103       Q -> R (in GALCT; dbSNP:rs367543252).
FT                                {ECO:0000269|PubMed:23022339}.
FT                                /FTId=VAR_068825.
FT   VARIANT     112    112       S -> R (in GALCT).
FT                                {ECO:0000269|PubMed:18956253}.
FT                                /FTId=VAR_068536.
FT   VARIANT     113    113       D -> N (in GALCT; dbSNP:rs111033677).
FT                                /FTId=VAR_002561.
FT   VARIANT     114    114       H -> L (in GALCT; dbSNP:rs111033678).
FT                                /FTId=VAR_002562.
FT   VARIANT     117    117       F -> S (in GALCT; dbSNP:rs111033679).
FT                                /FTId=VAR_002563.
FT   VARIANT     118    118       Q -> H (in GALCT; dbSNP:rs111033673).
FT                                /FTId=VAR_002564.
FT   VARIANT     123    123       R -> G (in GALCT; dbSNP:rs111033674).
FT                                {ECO:0000269|PubMed:9222760}.
FT                                /FTId=VAR_002565.
FT   VARIANT     123    123       R -> Q (in GALCT; dbSNP:rs111033675).
FT                                /FTId=VAR_002566.
FT   VARIANT     125    125       V -> A (in GALCT; dbSNP:rs111033680).
FT                                /FTId=VAR_002567.
FT   VARIANT     127    127       K -> E (in GALCT; dbSNP:rs111033682).
FT                                /FTId=VAR_002568.
FT   VARIANT     129    129       M -> T (in GALCT; dbSNP:rs111033683).
FT                                {ECO:0000269|PubMed:11919338}.
FT                                /FTId=VAR_008043.
FT   VARIANT     130    130       C -> Y (in GALCT; dbSNP:rs367543255).
FT                                /FTId=VAR_002569.
FT   VARIANT     132    132       H -> Q (in GALCT; affects protein
FT                                stability; dbSNP:rs367543256).
FT                                {ECO:0000269|PubMed:22461411}.
FT                                /FTId=VAR_068537.
FT   VARIANT     132    132       H -> Y (in GALCT; dbSNP:rs111033688).
FT                                /FTId=VAR_002570.
FT   VARIANT     135    135       S -> L (in GALCT; frequent mutation in
FT                                African Americans; about 5% of normal
FT                                galactose uridylyltransferase activity;
FT                                dbSNP:rs111033690).
FT                                {ECO:0000269|PubMed:11754113,
FT                                ECO:0000269|PubMed:1610789,
FT                                ECO:0000269|PubMed:22461411,
FT                                ECO:0000269|PubMed:25614870,
FT                                ECO:0000269|PubMed:7887417}.
FT                                /FTId=VAR_002571.
FT   VARIANT     135    135       S -> W (in GALCT; dbSNP:rs111033690).
FT                                {ECO:0000269|PubMed:15841485}.
FT                                /FTId=VAR_023329.
FT   VARIANT     138    138       T -> M (in GALCT; mild;
FT                                dbSNP:rs111033686).
FT                                {ECO:0000269|PubMed:11754113}.
FT                                /FTId=VAR_002572.
FT   VARIANT     139    139       L -> P (in GALCT; dbSNP:rs111033687).
FT                                /FTId=VAR_002573.
FT   VARIANT     142    142       M -> K (in GALCT; 4% of normal activity;
FT                                dbSNP:rs111033695).
FT                                {ECO:0000269|PubMed:10220154,
FT                                ECO:0000269|PubMed:2011574}.
FT                                /FTId=VAR_002574.
FT   VARIANT     142    142       M -> T (in GALCT; dbSNP:rs111033695).
FT                                {ECO:0000269|PubMed:25592817}.
FT                                /FTId=VAR_072795.
FT   VARIANT     142    142       M -> V (in GALCT; dbSNP:rs111033692).
FT                                /FTId=VAR_002575.
FT   VARIANT     143    143       S -> L (in GALCT; dbSNP:rs111033697).
FT                                {ECO:0000269|PubMed:9222760}.
FT                                /FTId=VAR_002576.
FT   VARIANT     148    148       R -> G (in GALCT; dbSNP:rs111033693).
FT                                /FTId=VAR_002577.
FT   VARIANT     148    148       R -> Q (in GALCT; dbSNP:rs111033694).
FT                                {ECO:0000269|PubMed:25614870}.
FT                                /FTId=VAR_002578.
FT   VARIANT     148    148       R -> W (in GALCT; unstable protein;
FT                                dbSNP:rs111033693).
FT                                {ECO:0000269|PubMed:1373122}.
FT                                /FTId=VAR_002579.
FT   VARIANT     150    150       V -> L (in GALCT; dbSNP:rs111033699).
FT                                {ECO:0000269|PubMed:8956044}.
FT                                /FTId=VAR_002580.
FT   VARIANT     151    151       V -> A (in GALCT; approximatively 3% of
FT                                normal activity; dbSNP:rs111033701).
FT                                {ECO:0000269|PubMed:7887417}.
FT                                /FTId=VAR_002581.
FT   VARIANT     154    154       W -> G (in GALCT; dbSNP:rs111033702).
FT                                /FTId=VAR_002582.
FT   VARIANT     166    166       P -> A (in GALCT; dbSNP:rs367543257).
FT                                {ECO:0000269|PubMed:23022339}.
FT                                /FTId=VAR_068826.
FT   VARIANT     167    167       W -> R (in GALCT; dbSNP:rs111033708).
FT                                /FTId=VAR_008044.
FT   VARIANT     168    168       V -> L (in GALCT; loss of activity;
FT                                dbSNP:rs367543258).
FT                                {ECO:0000269|PubMed:22461411}.
FT                                /FTId=VAR_068538.
FT   VARIANT     170    170       I -> T (in GALCT; loss of activity;
FT                                dbSNP:rs111033839).
FT                                {ECO:0000269|PubMed:22461411}.
FT                                /FTId=VAR_068539.
FT   VARIANT     171    171       F -> S (in GALCT; reduced enzyme
FT                                activity; dbSNP:rs111033715).
FT                                {ECO:0000269|PubMed:1610789,
FT                                ECO:0000269|PubMed:23022339}.
FT                                /FTId=VAR_002583.
FT   VARIANT     175    175       G -> D (in GALCT; reduces strongly
FT                                galactose uridylyltransferase activity;
FT                                dbSNP:rs111033718).
FT                                {ECO:0000269|PubMed:25614870}.
FT                                /FTId=VAR_072796.
FT   VARIANT     179    179       G -> D (in GALCT; dbSNP:rs111033720).
FT                                /FTId=VAR_002584.
FT   VARIANT     181    181       S -> A (in GALCT; dbSNP:rs111033828).
FT                                {ECO:0000269|PubMed:17041746}.
FT                                /FTId=VAR_068540.
FT   VARIANT     181    181       S -> F (in GALCT; dbSNP:rs367543259).
FT                                {ECO:0000269|PubMed:23022339}.
FT                                /FTId=VAR_068827.
FT   VARIANT     183    183       P -> T (in GALCT; dbSNP:rs111033721).
FT                                {ECO:0000269|PubMed:8869397,
FT                                ECO:0000269|PubMed:8956044}.
FT                                /FTId=VAR_002585.
FT   VARIANT     184    184       H -> Q (in GALCT; dbSNP:rs111033717).
FT                                {ECO:0000269|PubMed:11754113}.
FT                                /FTId=VAR_002586.
FT   VARIANT     185    185       P -> H (in GALCT; loss of activity;
FT                                dbSNP:rs111033722).
FT                                {ECO:0000269|PubMed:17876724,
FT                                ECO:0000269|PubMed:22461411}.
FT                                /FTId=VAR_068541.
FT   VARIANT     185    185       P -> L (in GALCT; dbSNP:rs111033722).
FT                                {ECO:0000269|PubMed:23022339}.
FT                                /FTId=VAR_068828.
FT   VARIANT     185    185       P -> S (in GALCT; dbSNP:rs111033826).
FT                                {ECO:0000269|PubMed:17041746,
FT                                ECO:0000269|PubMed:25614870}.
FT                                /FTId=VAR_068542.
FT   VARIANT     188    188       Q -> R (in GALCT; most common mutation;
FT                                accounts for approximately 70% of GALCT
FT                                alleles tested; 10% of normal galactose
FT                                uridylyltransferase activity;
FT                                dbSNP:rs75391579).
FT                                {ECO:0000269|PubMed:11754113,
FT                                ECO:0000269|PubMed:1427861,
FT                                ECO:0000269|PubMed:18956253,
FT                                ECO:0000269|PubMed:1897530,
FT                                ECO:0000269|PubMed:22461411,
FT                                ECO:0000269|PubMed:23022339,
FT                                ECO:0000269|PubMed:25592817,
FT                                ECO:0000269|PubMed:25614870,
FT                                ECO:0000269|PubMed:7887417,
FT                                ECO:0000269|PubMed:8956044}.
FT                                /FTId=VAR_002587.
FT   VARIANT     192    192       S -> G (in GALCT; dbSNP:rs111033830).
FT                                {ECO:0000269|PubMed:17041746}.
FT                                /FTId=VAR_068543.
FT   VARIANT     192    192       S -> N (in GALCT; dbSNP:rs111033734).
FT                                /FTId=VAR_002588.
FT   VARIANT     194    194       F -> L (in GALCT; dbSNP:rs111033726).
FT                                /FTId=VAR_002589.
FT   VARIANT     195    195       L -> P (in GALCT; no enzymatic activity;
FT                                dbSNP:rs111033728).
FT                                {ECO:0000269|PubMed:11754113,
FT                                ECO:0000269|PubMed:1373122}.
FT                                /FTId=VAR_002590.
FT   VARIANT     198    198       I -> M (in GALCT; dbSNP:rs111033729).
FT                                /FTId=VAR_002591.
FT   VARIANT     198    198       I -> T (in GALCT).
FT                                /FTId=VAR_002592.
FT   VARIANT     199    199       A -> T (in GALCT; dbSNP:rs111033730).
FT                                /FTId=VAR_002593.
FT   VARIANT     201    201       R -> C (in GALCT; 2-fold decrease in
FT                                activity; dbSNP:rs111033739).
FT                                {ECO:0000269|PubMed:17876724,
FT                                ECO:0000269|PubMed:22461411}.
FT                                /FTId=VAR_068544.
FT   VARIANT     201    201       R -> H (in GALCT; dbSNP:rs111033735).
FT                                /FTId=VAR_002594.
FT   VARIANT     203    203       E -> K (in GALCT; dbSNP:rs111033736).
FT                                /FTId=VAR_002595.
FT   VARIANT     204    204       R -> P (in GALCT; dbSNP:rs111033740).
FT                                /FTId=VAR_008045.
FT   VARIANT     209    209       Y -> C (in GALCT; dbSNP:rs111033744).
FT                                /FTId=VAR_002596.
FT   VARIANT     209    209       Y -> S (in GALCT; dbSNP:rs111033744).
FT                                /FTId=VAR_002597.
FT   VARIANT     212    212       Q -> H (in GALCT).
FT                                /FTId=VAR_002598.
FT   VARIANT     217    217       L -> P (in GALCT; dbSNP:rs111033741).
FT                                /FTId=VAR_002599.
FT   VARIANT     220    220       E -> K (in GALCT; 3-fold decrease in
FT                                activity; dbSNP:rs111033747).
FT                                {ECO:0000269|PubMed:17876724,
FT                                ECO:0000269|PubMed:22461411}.
FT                                /FTId=VAR_068545.
FT   VARIANT     223    223       R -> S (in GALCT; 3-fold decrease in
FT                                activity; dbSNP:rs111033750).
FT                                {ECO:0000269|PubMed:17876724,
FT                                ECO:0000269|PubMed:22461411}.
FT                                /FTId=VAR_068546.
FT   VARIANT     226    226       L -> P (in GALCT; dbSNP:rs111033752).
FT                                /FTId=VAR_002600.
FT   VARIANT     227    227       L -> P (in GALCT; results in no
FT                                detectable protein in the soluble
FT                                fraction; dbSNP:rs111033846).
FT                                {ECO:0000269|PubMed:22461411}.
FT                                /FTId=VAR_068547.
FT   VARIANT     229    229       K -> N (in GALCT; dbSNP:rs111033753).
FT                                {ECO:0000269|PubMed:15841485}.
FT                                /FTId=VAR_023330.
FT   VARIANT     231    231       R -> C (in GALCT; dbSNP:rs111033749).
FT                                {ECO:0000269|PubMed:25614870}.
FT                                /FTId=VAR_072797.
FT   VARIANT     231    231       R -> H (in GALCT; 15% of normal activity;
FT                                dbSNP:rs111033754).
FT                                {ECO:0000269|PubMed:25614870,
FT                                ECO:0000269|PubMed:7550229}.
FT                                /FTId=VAR_002601.
FT   VARIANT     244    244       P -> S (in GALCT).
FT                                {ECO:0000269|PubMed:25592817}.
FT                                /FTId=VAR_072798.
FT   VARIANT     249    249       W -> R (in GALCT; dbSNP:rs111033757).
FT                                /FTId=VAR_002602.
FT   VARIANT     251    251       Y -> C (in GALCT; dbSNP:rs111033755).
FT                                /FTId=VAR_002603.
FT   VARIANT     251    251       Y -> S (in GALCT; dbSNP:rs111033755).
FT                                {ECO:0000269|PubMed:11754113}.
FT                                /FTId=VAR_002604.
FT   VARIANT     252    252       Q -> H (in GALCT; dbSNP:rs111033769).
FT                                {ECO:0000269|PubMed:15841485}.
FT                                /FTId=VAR_023331.
FT   VARIANT     258    258       R -> C (in GALCT; dbSNP:rs368166217).
FT                                /FTId=VAR_002605.
FT   VARIANT     259    259       R -> Q (in GALCT; loss of activity).
FT                                {ECO:0000269|PubMed:22461411}.
FT                                /FTId=VAR_068548.
FT   VARIANT     259    259       R -> W (in GALCT; mild;
FT                                dbSNP:rs786204763).
FT                                /FTId=VAR_002606.
FT   VARIANT     262    262       R -> P (in GALCT; dbSNP:rs111033763).
FT                                /FTId=VAR_002607.
FT   VARIANT     263    263       Missing (in GALCT).
FT                                /FTId=VAR_008046.
FT   VARIANT     265    265       P -> A (in GALCT; dbSNP:rs111033764).
FT                                {ECO:0000269|PubMed:17041746}.
FT                                /FTId=VAR_068549.
FT   VARIANT     267    267       L -> R (in GALCT).
FT                                {ECO:0000269|PubMed:25592817}.
FT                                /FTId=VAR_072799.
FT   VARIANT     267    267       L -> V (in GALCT).
FT                                {ECO:0000269|PubMed:25592817}.
FT                                /FTId=VAR_072800.
FT   VARIANT     271    271       E -> D (in GALCT).
FT                                {ECO:0000269|PubMed:25592817}.
FT                                /FTId=VAR_072801.
FT   VARIANT     272    272       R -> G (in GALCT; dbSNP:rs111033766).
FT                                /FTId=VAR_008047.
FT   VARIANT     278    278       I -> N (in GALCT; 18-fold decrease in
FT                                activity; dbSNP:rs111033778).
FT                                {ECO:0000269|PubMed:17876724,
FT                                ECO:0000269|PubMed:22461411}.
FT                                /FTId=VAR_068550.
FT   VARIANT     282    282       L -> V (in GALCT; dbSNP:rs111033772).
FT                                /FTId=VAR_002608.
FT   VARIANT     285    285       K -> N (in GALCT; severe; 25-40% of the
FT                                European population; dbSNP:rs111033773).
FT                                {ECO:0000269|PubMed:10220154,
FT                                ECO:0000269|PubMed:11754113,
FT                                ECO:0000269|PubMed:25592817,
FT                                ECO:0000269|PubMed:25614870}.
FT                                /FTId=VAR_002609.
FT   VARIANT     285    285       K -> R (in GALCT; dbSNP:rs367543263).
FT                                {ECO:0000269|PubMed:23022339}.
FT                                /FTId=VAR_068829.
FT   VARIANT     289    289       L -> F (in GALCT; 3-fold decrease in
FT                                activity; dbSNP:rs111033774).
FT                                {ECO:0000269|PubMed:17876724,
FT                                ECO:0000269|PubMed:22461411}.
FT                                /FTId=VAR_068551.
FT   VARIANT     289    289       L -> R (in GALCT; dbSNP:rs111033775).
FT                                /FTId=VAR_002610.
FT   VARIANT     291    291       E -> K (in GALCT; dbSNP:rs111033780).
FT                                /FTId=VAR_002611.
FT   VARIANT     291    291       E -> V (in GALCT; 2-fold decrease in
FT                                activity; dbSNP:rs111033841).
FT                                {ECO:0000269|PubMed:22461411}.
FT                                /FTId=VAR_068552.
FT   VARIANT     294    294       F -> Y (in GALCT; dbSNP:rs111033781).
FT                                {ECO:0000269|PubMed:10220154}.
FT                                /FTId=VAR_008048.
FT   VARIANT     308    308       E -> K (in GALCT; dbSNP:rs111033784).
FT                                /FTId=VAR_002612.
FT   VARIANT     314    314       N -> D (in GALCT; allele Duarte; exists
FT                                as allelic variants Duarte-1 and Duarte-
FT                                2; Duarte-1 has normal or increased
FT                                activity; Duarte-2 has activity reduced
FT                                to about 35-45% of normal;
FT                                dbSNP:rs2070074).
FT                                {ECO:0000269|PubMed:11754113,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:18956253,
FT                                ECO:0000269|PubMed:2011574,
FT                                ECO:0000269|PubMed:23022339,
FT                                ECO:0000269|PubMed:25592817,
FT                                ECO:0000269|PubMed:25614870,
FT                                ECO:0000269|PubMed:7550229,
FT                                ECO:0000269|PubMed:8112740,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_002613.
FT   VARIANT     317    317       Q -> H (in GALCT; dbSNP:rs111033787).
FT                                /FTId=VAR_002614.
FT   VARIANT     317    317       Q -> R (in GALCT; dbSNP:rs111033786).
FT                                /FTId=VAR_002615.
FT   VARIANT     319    319       H -> Q (in GALCT; dbSNP:rs111033792).
FT                                {ECO:0000269|PubMed:23022339,
FT                                ECO:0000269|PubMed:8499924,
FT                                ECO:0000269|PubMed:8956044}.
FT                                /FTId=VAR_002616.
FT   VARIANT     320    320       A -> T (in GALCT; dbSNP:rs111033795).
FT                                {ECO:0000269|PubMed:10220154}.
FT                                /FTId=VAR_002617.
FT   VARIANT     323    323       Y -> D (in GALCT; dbSNP:rs111033796).
FT                                /FTId=VAR_002618.
FT   VARIANT     323    323       Y -> H (in GALCT; dbSNP:rs111033796).
FT                                /FTId=VAR_002619.
FT   VARIANT     324    324       P -> S (in GALCT; dbSNP:rs111033798).
FT                                /FTId=VAR_002620.
FT   VARIANT     325    325       P -> L (in GALCT; dbSNP:rs111033794).
FT                                {ECO:0000269|PubMed:9222760}.
FT                                /FTId=VAR_002621.
FT   VARIANT     327    327       L -> P (in GALCT; results in no
FT                                detectable protein in the soluble
FT                                fraction; dbSNP:rs111033832).
FT                                {ECO:0000269|PubMed:22461411}.
FT                                /FTId=VAR_068553.
FT   VARIANT     328    328       R -> H (in GALCT; dbSNP:rs111033802).
FT                                /FTId=VAR_002622.
FT   VARIANT     329    329       S -> F (in GALCT; dbSNP:rs111033803).
FT                                {ECO:0000269|PubMed:8741038}.
FT                                /FTId=VAR_002623.
FT   VARIANT     330    330       A -> V (in GALCT; mild;
FT                                dbSNP:rs111033804).
FT                                {ECO:0000269|PubMed:8598637}.
FT                                /FTId=VAR_002624.
FT   VARIANT     333    333       R -> G (in GALCT; dbSNP:rs111033800).
FT                                /FTId=VAR_002625.
FT   VARIANT     333    333       R -> L (in GALCT; dbSNP:rs111033808).
FT                                {ECO:0000269|PubMed:23022339}.
FT                                /FTId=VAR_068830.
FT   VARIANT     333    333       R -> Q (in GALCT; dbSNP:rs111033808).
FT                                /FTId=VAR_002626.
FT   VARIANT     333    333       R -> W (in GALCT; no enzymatic activity;
FT                                dbSNP:rs111033800).
FT                                {ECO:0000269|PubMed:1897530,
FT                                ECO:0000269|PubMed:25592817,
FT                                ECO:0000269|PubMed:7550229}.
FT                                /FTId=VAR_002627.
FT   VARIANT     334    334       K -> R (in GALCT; dbSNP:rs111033809).
FT                                /FTId=VAR_002628.
FT   VARIANT     336    336       M -> L (in GALCT; dbSNP:rs111033810).
FT                                /FTId=VAR_002629.
FT   VARIANT     342    342       L -> I (in GALCT; dbSNP:rs111033812).
FT                                {ECO:0000269|PubMed:11919338}.
FT                                /FTId=VAR_068554.
FT   VARIANT     344    344       Q -> K (in GALCT; dbSNP:rs111033814).
FT                                {ECO:0000269|PubMed:11754113}.
FT                                /FTId=VAR_002630.
FT   VARIANT     345    345       A -> D (in GALCT; dbSNP:rs111033815).
FT                                {ECO:0000269|PubMed:11754113}.
FT                                /FTId=VAR_068555.
FT   VARIANT     350    350       T -> A (in GALCT; mild;
FT                                dbSNP:rs111033817).
FT                                /FTId=VAR_002631.
FT   CONFLICT    258    259       RR -> VG (in Ref. 1; AAC83409).
FT                                {ECO:0000305}.
FT   CONFLICT    335    335       F -> L (in Ref. 5; BAG64359).
FT                                {ECO:0000305}.
FT   TURN         26     28       {ECO:0000244|PDB:5IN3}.
FT   STRAND       31     35       {ECO:0000244|PDB:5IN3}.
FT   TURN         36     39       {ECO:0000244|PDB:5IN3}.
FT   STRAND       40     44       {ECO:0000244|PDB:5IN3}.
FT   STRAND       93     96       {ECO:0000244|PDB:5IN3}.
FT   STRAND      119    121       {ECO:0000244|PDB:5IN3}.
FT   STRAND      124    131       {ECO:0000244|PDB:5IN3}.
FT   HELIX       139    141       {ECO:0000244|PDB:5IN3}.
FT   HELIX       144    162       {ECO:0000244|PDB:5IN3}.
FT   STRAND      166    175       {ECO:0000244|PDB:5IN3}.
FT   HELIX       176    178       {ECO:0000244|PDB:5IN3}.
FT   STRAND      184    194       {ECO:0000244|PDB:5IN3}.
FT   HELIX       197    213       {ECO:0000244|PDB:5IN3}.
FT   HELIX       217    228       {ECO:0000244|PDB:5IN3}.
FT   STRAND      232    235       {ECO:0000244|PDB:5IN3}.
FT   STRAND      237    242       {ECO:0000244|PDB:5IN3}.
FT   STRAND      253    259       {ECO:0000244|PDB:5IN3}.
FT   HELIX       264    266       {ECO:0000244|PDB:5IN3}.
FT   HELIX       269    289       {ECO:0000244|PDB:5IN3}.
FT   STRAND      296    301       {ECO:0000244|PDB:5IN3}.
FT   HELIX       306    308       {ECO:0000244|PDB:5IN3}.
FT   STRAND      319    323       {ECO:0000244|PDB:5IN3}.
FT   STRAND      328    331       {ECO:0000244|PDB:5IN3}.
FT   HELIX       339    342       {ECO:0000244|PDB:5IN3}.
FT   STRAND      345    349       {ECO:0000244|PDB:5IN3}.
FT   HELIX       351    360       {ECO:0000244|PDB:5IN3}.
SQ   SEQUENCE   379 AA;  43363 MW;  99945FF99C4F0066 CRC64;
     MSRSGTDPQQ RQQASEADAA AATFRANDHQ HIRYNPLQDE WVLVSAHRMK RPWQGQVEPQ
     LLKTVPRHDP LNPLCPGAIR ANGEVNPQYD STFLFDNDFP ALQPDAPSPG PSDHPLFQAK
     SARGVCKVMC FHPWSDVTLP LMSVPEIRAV VDAWASVTEE LGAQYPWVQI FENKGAMMGC
     SNPHPHCQVW ASSFLPDIAQ REERSQQAYK SQHGEPLLME YSRQELLRKE RLVLTSEHWL
     VLVPFWATWP YQTLLLPRRH VRRLPELTPA ERDDLASIMK KLLTKYDNLF ETSFPYSMGW
     HGAPTGSEAG ANWNHWQLHA HYYPPLLRSA TVRKFMVGYE MLAQAQRDLT PEQAAERLRA
     LPEVHYHLGQ KDRETATIA
//
